These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28476847)

  • 21. Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers.
    Angioli R; Plotti F; Capriglione S; Scaletta G; Dugo N; Aloisi A; Piccolo CL; Del Vescovo R; Terranova C; Zobel BB
    Arch Gynecol Obstet; 2016 Nov; 294(6):1291-1298. PubMed ID: 27535757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer.
    Prueksaritanond N; Angsathapon S; Insin P
    Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of HE4 in differentiating benign and malignant endometrial pathology.
    Gąsiorowska E; Magnowska M; Iżycka N; Warchoł W; Nowak-Markwitz E
    Ginekol Pol; 2016; 87(4):260-4. PubMed ID: 27321096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
    Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
    Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
    Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
    Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
    Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of circulating tumour cells may add value in endometrial cancer management.
    Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.
    Kalogera E; Scholler N; Powless C; Weaver A; Drapkin R; Li J; Jiang SW; Podratz K; Urban N; Dowdy SC
    Gynecol Oncol; 2012 Feb; 124(2):270-5. PubMed ID: 22037318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative markers for the prediction of high-risk features in endometrial cancer.
    Panyavaranant P; Manchana T
    World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
    Zhang AM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
    Moore RG; Brown AK; Miller MC; Badgwell D; Lu Z; Allard WJ; Granai CO; Bast RC; Lu K
    Gynecol Oncol; 2008 Aug; 110(2):196-201. PubMed ID: 18495222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
    Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
    Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Wagrodzki M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():141-147. PubMed ID: 28624692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L
    Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
    Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
    Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4.
    Capriglione S; Plotti F; Miranda A; Lopez S; Scaletta G; Moncelli M; Luvero D; De Cicco Nardone C; Terranova C; Montera R; Angioli R
    Expert Rev Anticancer Ther; 2017 Jan; 17(1):9-18. PubMed ID: 27892774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
    Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.
    Reijnen C; IntHout J; Massuger LFAG; Strobbe F; Küsters-Vandevelde HVN; Haldorsen IS; Snijders MPLM; Pijnenborg JMA
    Oncologist; 2019 Sep; 24(9):e880-e890. PubMed ID: 31186375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.